Search

Showing "11155" results for ""

CROI: Atazanavir and atazanavir/ritonavir safe and effective in treatment-naive patients

CROI: Male circumcision reduces risk of transmission of HIV and some STIs to female partners

CROI: Two studies show single-dose nevirapine prevents HIV transmission in consecutive pregnancies

CROI: Abacavir gene testing reveals high levels of hypersensitivity mutation

Bristol Myers Squibb announces voluntary licenses for atazanavir in India and South Africa

CROI: Cotrimoxazole prophylaxis reduces adverse birth outcomes in Zambian women with HIV

News from the Thirteenth Conference on Retroviruses and Opportunistic Infections

CROI: Nearly one in fifty European patients may have suffered an opportunistic infection above the expected CD4 count

CROI: Rapid response predicts success in HIV/HCV coinfected patients

CROI: AZT, 3TC and FTC achieve good concentrations in the female genital tract; good candidates for PrEP?

CROI: More on sexual transmission of HCV in HIV+ gay men and heterosexual women

CROI: Liver fibrosis and noninvasive monitoring tools in HIV/HCV coinfected patients

CROI: Good responses to ART seen in women given nevirapine for mother-to-child transmission

CROI: Long-term use of HIV therapy has no strong association with liver-related death

CROI: Genetic diversity of HIV increasing in the UK

CROI: Saquinavir-based combination prevents mother-to-child HIV transmission

CROI: Are neutralising antibodies the key to superinfection?

CROI: Persistent brain impairment despite HIV treatment linked to severity of prior dementia

Receive the latest HIV research and conference news

Showing "11155" results for ""

CROI: Atazanavir and atazanavir/ritonavir safe and effective in treatment-naive patients

CROI: Male circumcision reduces risk of transmission of HIV and some STIs to female partners

CROI: Two studies show single-dose nevirapine prevents HIV transmission in consecutive pregnancies

CROI: Abacavir gene testing reveals high levels of hypersensitivity mutation

Bristol Myers Squibb announces voluntary licenses for atazanavir in India and South Africa

CROI: Cotrimoxazole prophylaxis reduces adverse birth outcomes in Zambian women with HIV

News from the Thirteenth Conference on Retroviruses and Opportunistic Infections

CROI: Nearly one in fifty European patients may have suffered an opportunistic infection above the expected CD4 count

CROI: Rapid response predicts success in HIV/HCV coinfected patients

CROI: AZT, 3TC and FTC achieve good concentrations in the female genital tract; good candidates for PrEP?

CROI: More on sexual transmission of HCV in HIV+ gay men and heterosexual women

CROI: Liver fibrosis and noninvasive monitoring tools in HIV/HCV coinfected patients

CROI: Good responses to ART seen in women given nevirapine for mother-to-child transmission

CROI: Long-term use of HIV therapy has no strong association with liver-related death

CROI: Genetic diversity of HIV increasing in the UK

CROI: Saquinavir-based combination prevents mother-to-child HIV transmission

CROI: Are neutralising antibodies the key to superinfection?

CROI: Persistent brain impairment despite HIV treatment linked to severity of prior dementia

Receive the latest HIV research and conference news